ADMA

Q: What is the price of ADMA Biologics (ADMA) today?

The price of ADMA Biologics (ADMA) today is US$ 14,54, with a variation of -14.52% compared to the last year. The price of ADMA Biologics (ADMA) started the year trading around US$ 17,15 and today it is at US$ 14,54. Follow the real-time price chart, the historical price of ADMA Biologics (ADMA), and stock data from Ibovespa and international markets.

Q: When does ADMA Biologics (ADMA) pay dividends?

ADMA Biologics (ADMA) did not distribute dividends in the last year.

Q: ADMA Biologics (ADMA) is it worth it?

Currently, ADMA Biologics (ADMA) is priced at US$ 14,54, with a P/E of 17,05%, representing a deviation of -20,39% from its historical average P/E. In the last year, the stock showed a variation of -14.52% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was -14,52%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of ADMA Biologics (ADMA)?

Investing in stocks of ADMA Biologics (ADMA) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of ADMA Biologics (ADMA) yield today?

The yield of ADMA Biologics (ADMA) was -7,74% in the last month, -14,52% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 stocks of ADMA Biologics (ADMA) today, the total investment would be US$ 1.454,00, based on the current price of US$ 14,54.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 1.242,88In 5 years: US$ 1.454,00In 10 years: 1.454,00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

ADMA Biologics Inc.

Price

US$ 14,54

variation (12m)

-14,52%

p/l

17,05

p/vp

8,87

DIVIDEND YIELD

0,00%

price ADMA

BVMF

ADMA

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of ADMA

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

-7,74%

3 months

-21,45%

1 year

-14,52%

2 years

336,64%

5 years

0,00%

10 years

0,00%

real profitability

profitability minus inflation.

1 month

-7,74%

3 months

-21,74%

1 year

-18,27%

2 years

298,53%

5 years

0,00%

10 years

0,00%

Indicators ADMA

check out the fundamentals of ADMA Biologics shares

P/E

17,05

Sector: -3,47 Industry: -3,47

P/SALES RATIO (PSR)

7,42

Sector: -4,23 Industry: -4,23

P/BV

8,87

Sector: 1,89 Industry: 1,89

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

37,11%

Sector: -63,87% Industry: -63,87%

ROE

52,03%

Sector: -70,87% Industry: -70,87%

ROIC

36,49%

Sector: -2.084,36% Industry: -2.084,36%

NET MARGIN

43,51%

Sector: -41,75% Industry: -41,75%

GROSS MARGIN

54,35%

Sector: 38,19% Industry: 38,19%

OPERATING MARGIN

33,34%

Sector: -41,04% Industry: -41,04%

P/EBITDA

21,68

Sector: -3,65 Industry: -3,65

P/EBIT

22,52

Sector: -3,64 Industry: -3,64

P/ASSET

6,33

Sector: 1,41 Industry: 1,41

BVPS

1,65

Sector: 1,84 Industry: 1,84

EPS

0,86

Sector: -2,20 Industry: -2,20

EQUITY / ASSETS

0,71

Sector: 0,42 Industry: 0,42

CAGR REVENUES 5 YEARS

62,29%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

0,00%

Sector: - Industry: -

FAIR PRICE OF ADMA Biologics ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 14,54

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-61,14%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

ADMA indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
JNJ	17,80	5,78	32,50%	2,69%	US$ 453,87 B	27,75%
PFE	16,92	1,75	10,33%	6,25%	US$ 155,60 B	15,13%
ABBV	108,79	-2.966,40	-2.726,81%	2,79%	US$ 409,36 B	6,45%
NVO	16,20	10,21	62,99%	2,83%	US$ 265,17 B	34,74%
MRK	12,67	4,56	36,03%	3,59%	US$ 223,87 B	28,16%
AZN	28,39	5,90	20,79%	1,83%	US$ 264,46 B	16,23%
BMY	17,97	5,29	29,44%	5,41%	US$ 92,49 B	10,71%
GILD	19,99	7,16	35,82%	2,79%	US$ 140,30 B	24,71%
ZTS	24,61	13,09	53,20%	1,32%	US$ 65,16 B	28,00%
HALO	14,26	25,08	175,93%	0,00%	US$ 8,35 B	48,21%
REGN	13,97	2,10	15,06%	0,44%	US$ 63,00 B	31,83%
AMGN	30,70	21,58	70,29%	3,15%	US$ 160,26 B	14,67%
VRTX	28,59	6,03	21,11%	0,00%	US$ 103,65 B	31,22%
MCK	24,89	-106,90	-429,55%	0,40%	US$ 92,26 B	0,97%
CAH	26,56	-13,96	-52,54%	1,31%	US$ 36,76 B	0,60%
BIIB	13,23	1,33	10,08%	0,00%	US$ 23,50 B	17,46%
HRMY	8,91	2,01	22,58%	0,00%	US$ 1,55 B	22,19%

comparison of ADMA with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History ADMA

current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY ADMA Biologics

ADMA Biologics Inc.

Average user rating I10

4.0 (13 people)

Estados Unidos

21 years

Foundation: 2004

2013

Year of debut on the stock exchange - 12 years

407

Employees

The Company ADMA Biologics Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 3,53 Billions, having a net worth of $ 398,32 Milhões.

With a total of 407 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 476,31 Milhões, which generated a profit in the amount of $ 207,24 Milhões.

As for its main indicators, the Company has a P/E ratio of 17,05, a P/BV ratio of 8,87 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker ADMA.

Market value

US$ 3,53 Billions

Net worth

US$ 398,32 Milhões

US$ 398.320.000,00

Assets

US$ 558,38 Milhões

US$ 558.380.000,00

Total Number of Shares

241,00 Milhões

241.000.000

Average Daily Trading Volume

US$ 3,34 Milhões

US$ 3.338.467,82

Sector

Health Care

Industry

Biotechnology

ADMA

ADMA revenue and profits

ADMA results

DRAG THE FRAME TO SEE MORE DATA

ADMA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 763,55 51,69% (12M)

P/L

24,89

0,40%

ROE

-429,55%

P/VP

-106,90

CAH - Cardinal Health

US$ 156,88 42,09% (12M)

P/L

26,56

1,31%

ROE

-52,54%

P/VP

-13,96

JNJ - Johnson & Johnson

US$ 190,72 21,94% (12M)

P/L

17,80

2,69%

ROE

32,50%

P/VP

5,78

MRK - Merck & Co.

US$ 85,99 --18,73% (12M)

P/L

12,67

3,59%

ROE

36,03%

P/VP

4,56

ABBV - AbbVie

US$ 230,50 23,82% (12M)

P/L

108,79

2,79%

ROE

-2.726,81%

P/VP

-2.966,40

PFE - Pfizer

US$ 24,78 --8,77% (12M)

P/L

16,92

6,25%

ROE

10,33%

P/VP

1,75

AZN - AstraZeneca

US$ 84,53 11,61% (12M)

P/L

28,39

1,83%

ROE

20,79%

P/VP

5,90

BFRA - Biofrontera

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 763,55 51,69% (12 M)

P/L

24,89

0,40%

ROE

-429,55%

P/VP

-106,90

CAH - Cardinal Health

US$ 156,88 42,09% (12 M)

P/L

26,56

1,31%

ROE

-52,54%

P/VP

-13,96

JNJ - Johnson & Johnson

US$ 190,72 21,94% (12 M)

P/L

17,80

2,69%

ROE

32,50%

P/VP

5,78

MRK - Merck & Co.

US$ 85,99 --18,73% (12 M)

P/L

12,67

3,59%

ROE

36,03%

P/VP

4,56

ABBV - AbbVie

US$ 230,50 23,82% (12 M)

P/L

108,79

2,79%

ROE

-2.726,81%

P/VP

-2.966,40

PFE - Pfizer

US$ 24,78 --8,77% (12 M)

P/L

16,92

6,25%

ROE

10,33%

P/VP

1,75

AZN - AstraZeneca

US$ 84,53 11,61% (12 M)

P/L

28,39

1,83%

ROE

20,79%

P/VP

5,90

Frequently Asked Questions

What is the price of ADMA Biologics (ADMA) today?

The price of ADMA Biologics (ADMA) today is US$ 14,54, with a variation of -14.52% compared to the last year. The price of ADMA Biologics (ADMA) started the year trading around US$ 17,15 and today it is at US$ 14,54. Follow the real-time price chart, the historical price of ADMA Biologics (ADMA), and stock data from Ibovespa and international markets.

When does ADMA Biologics (ADMA) pay dividends?

ADMA Biologics (ADMA) did not distribute dividends in the last year.

ADMA Biologics (ADMA) is it worth it?

Currently, ADMA Biologics (ADMA) is priced at US$ 14,54, with a P/E of 17,05%, representing a deviation of -20,39% from its historical average P/E. In the last year, the stock showed a variation of -14.52% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was -14,52%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy stocks of ADMA Biologics (ADMA)?

Investing in stocks of ADMA Biologics (ADMA) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 stocks of ADMA Biologics (ADMA) yield today?

The yield of ADMA Biologics (ADMA) was -7,74% in the last month, -14,52% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 stocks of ADMA Biologics (ADMA) today, the total investment would be US$ 1.454,00, based on the current price of US$ 14,54.

If past performance were to repeat, the return on your investment would be:

In 1 year: US$ 1.242,88
In 5 years: US$ 1.454,00
In 10 years: 1.454,00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

ADMA

ADMA Biologics Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of ADMA

check out the fundamentals of ADMA Biologics shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY ADMA Biologics

ADMA Biologics Inc.

Estados Unidos

21 years

2013

407

PROFIT X PRICE ADMA

ADMA results

ADMA cash flow

evolution of assets - ADMA

ADMA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

Frequently Asked Questions